R. Knight

Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell transplantation is associated with chronic GVHD requiring immunosuppressive therapy, but no adverse impact on OS or relapse.

Philipp W. Raess, E. Traer, P. Raess, 2021, Transplantation and cellular therapy.

Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors.

R. Maziarz, L. Newell, S. Slater, 2019, Cytotherapy.

Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates.

R. Maziarz, L. Newell, R. Cook, 2023, Cytotherapy.

Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization

J. Bubalo, T. Bains, S. Slater, 2012, Bone Marrow Transplantation.